CClinicalTrials.gg
CompletedNCT05260918Updated Jul 21, 2023

Examining the Effects of Float-REST for Recovery in Individuals With Chronic Lower Back Pain

An interventional study of Float-REST and Nappod in Pain, Chronic, sponsored by West Virginia University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-07-21.

Sponsored by West Virginia University · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Researchers at the West Virginia University Rockefeller Neuroscience Institute are looking for volunteers to participate in a research study to evaluate what effects Float-REST (Restricted environmental Stimulation Technique) has on the stress response caused by chronic lower back pain.

Read the detailed description

Chronic lower back pain has a profound impact on a patient's life and body. These patients face a litany of internal and external stressors. These stressors cause a detrimental sustained activation of the endogenous stress response, which is mediated by the autonomic nervous system. Our central hypothesis is that this high stress load exacerbates the symptoms of chronic pain by causing changes in how the brain processes pain signals from the periphery. If researchers can better understand how stress plays a role in the mitigation of pain, then there may be improvements in patient's quality of life. Restricted Environmental Stimulation Therapy (REST) flotation has been identified as a possible alternative treatment to pharmacological intervention for several conditions like generalized anxiety disorder by helping to reduce stress. However, there have yet to be any investigation into what affects that REST flotation has in chronic lower back pain.

02

Conditions studied

  • Pain, Chronic

Keywords

  • Sensory Deprivation Tank
  • fMRI
03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

This study's enrollment of 24 is below the median of 60 across 1,941 interventional studies indexed under Back Pain.

Browse Back Pain studies →

Lead sponsor

West Virginia University is the lead sponsor of 155 studies on the registry; 35 are open to participants now.

Of its 19 completed or terminated interventional studies of FDA-regulated products, 16 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Able and willing to give informed consent
  • Right-hand dominant
  • Naïve to mindfulness interventions (i.e. guided meditation, guided yoga, previous REST flotation)
  • Have chronic lower back pain (at least 12 weeks since onset)
  • Ability to enter/exit REST Flotation Tank unassisted
  • Stable prescription medication (No changes in dose, start/stop within 30 days of the beginning of the study)

Exclusion criteria

Exclusion Criteria:

  • MRI incompatibility: The participant cannot have any non-MRI compatible metallic (magnetic) material in, on, or attached to their body.
  • Current fear of small spaces or water
  • Current balance problems or motion sickness
  • Body width greater than 60cm
  • Current contagious skin condition
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (actual)

Study arms

  • Active comparator
    Flotation-REST

    Float-REST therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salt to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the participant to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. The room will contain an intercom that allows participants to communicate with study personnel in the event the participant needs assistance. Participants will undergo 60 minute sessions twice a week for 3 weeks.

    Other: Float-REST

  • Placebo comparator
    Nappod

    Participants in this arm will be asked to lie comfortably in a special recliner called a Metro Nappod for the duration of a 60 minute session twice a week for 3 weeks. The chair is located in a quiet and dimly lit room to minimize interruptions. The pod is equipped with a privacy visor, built-in speaker, and a timer with an alarm.

    Other: Nappod

Interventions

  • OtherFloat-REST

    Participants will utilize sensory deprivation tanks.

  • OtherNappod

    Participants will utilize nappod.

06

What researchers measure

Primary outcomes

  1. Changes in Functional Magnetic Resonance Imaging (fMRI)

    fMRI analysis looks at alterations in brain activity from baseline at rest and in response to pain cues

    Time frame: Participants will undergo an fMRI session at the beginning (Week 1) to establish a baseline and a follow up end of the study (Week 8).

Secondary outcomes

  1. Change in Nocturnal Heart Rate as measured by OURA Ring

    Heart rate (beats per minute) will be quantified throughout the night via the OURA ring.

    Time frame: Daily from baseline through study completion at 8 weeks

  2. Change in daily self-report measures for task load

    End of Day Questionnaire (EoD)-Developed at the Rockefeller Neuroscience Institute (RNI) as a modification of the NASA Task Load Index. There are 5 Likert scales to assess workload (0=very low and 100=very high), as well as 4 follow up questions. This questionnaire addresses subjective measures of workload and stressors that were encountered throughout the day.

    Time frame: Daily from baseline through study completion at 8 weeks

  3. Change in per session self-report measures

    State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions. Values range from 20 to 80, with higher scores representing more severe anxiety. Participants will complete the STAI questionnaire before and after each session, twice a week.

    Time frame: Before and after each float session (Weeks 2-7)

  4. Change in testing battery self-report measures in personality

    Big Five Inventory (BFI)-44 item inventory designed to measure the Big Five Factors of personality on a 5-point Likert Scale. Higher scores indicate a higher tendency for that personality trait (1=disagree strongly to 5=agree strongly).

    Time frame: Beginning and end of the investigation (Week 1 & Week 8)

  5. Change in testing battery self-report measures in emotional regulation

    Emotion Regulation Questionnaire (ERQ)-10-item scale designed to measure tendency to regulate emotions. Each item is answered on a 7-point Likert Scale (1=strongly disagree to 7=strongly agree). Higher scores indicate a higher emotion regulation strategy.

    Time frame: Beginning and end of the investigation (Week 1 & Week 8)

  6. Change in testing battery self-report measures in mindfulness

    Five Facet Mindfulness Questionnaire (FFMQ)-39 item inventory assesses the five facets of mindfulness on a 5-point Likert Scale (1=never or very rarely true and 5=very often or always true). Each facet is tallied and the sum total responses are divided by 39 (number of items). Higher scores indicate higher levels of mindfulness.

    Time frame: Beginning and end of the investigation (Week 1 & Week 8)

  7. Change in testing battery self-report measures in sleep quality

    Pittsburgh Sleep Quality Index (PSQI)- 19 item inventory with 7 subjective components that assess sleep quality over time. Each component is scored from 0 to 3 (0=very good and 3=very bad). The sum of the components is the global score and ranges 0-21 (0=no difficulty and 21=severe difficulties). The higher the global score, the poorer the sleep quality.

    Time frame: Beginning and end of the investigation (Week 1 & Week 8)

  8. Cold Pressor Stressor

    The cold pressor is a water bath with its temperature maintained at 3C. The participant is asked to submerge a hand in the water bath. The water is cold enough to be a painful stimuli but not so cold as to cause tissue damage. The participant rates their pain level on a standard Wong-Baker pain scale prior and immediately after voluntary withdraw from the cold pressor. The Wong Baker pain scale asks the participant to rate their pain on a scale of 0-10 with 0= no pain and 10= the most pain. Duration of time spent in the water is also recorded.

    Time frame: The participant will undergo the cold pressor test at the beginning (Week 1) and end of the study (Week 8) with the option for an additional session after a few sessions at the investigators discretion.

  9. Serum Analysis for changes in Interleukin 1B concentration

    Blood samples will be collected through out the study and analyzed for a key stress indicators Interleukin 1B.

    Time frame: Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)

  10. Serum Analysis for changes in Interleukin 6 concentration

    Blood samples will be collected through out the study and analyzed for a key stress indicators Interleukin 6.

    Time frame: Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)

  11. Serum Analysis for changes in Cortisol concentration

    Blood samples will be collected through out the study and analyzed for a key stress indicator Cortisol.

    Time frame: Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)

  12. Changes in Serum Analysis for changes in Dehydroepiandrosterone concentration

    Blood samples will be collected through out the study and analyzed for a key stress indicator Dehydroepiandrosterone.

    Time frame: Beginning (Week 1), middle (Week 5), and end of the investigation (Week 8)

07

Study locations

1 site
  • Rockefeller Neuroscience Institute at West Virginia University
    Morgantown, West Virginia 26505, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 21, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05260918
Lead sponsor
West Virginia University
Responsible party
Sponsor
First posted
Mar 2, 2022
Start date
Feb 24, 2022
Primary completion
Jan 1, 2023
Completion
Jan 1, 2023
Last update
Jul 21, 2023

Study contacts

Victor S Finomore, PhD
principal investigator · West Virginia University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion